Normal vs cancer thyroid stem cells: The road to transformation

M. Zane, E. Scavo, V. Catalano, M. Bonanno, M. Todaro, R. De Maria, G. Stassi

Research output: Contribution to journalArticle

Abstract

Recent investigations in thyroid carcinogenesis have led to the isolation and characterisation of a subpopulation of stem-like cells, responsible for tumour initiation, progression and metastasis. Nevertheless, the cellular origin of thyroid cancer stem cells (SCs) remains unknown and it is still necessary to define the process and the target population that sustain malignant transformation of tissue-resident SCs or the reprogramming of a more differentiated cell. Here, we will critically discuss new insights into thyroid SCs as a potential source of cancer formation in light of the available information on the oncogenic role of genetic modifications that occur during thyroid cancer development. Understanding the fine mechanisms that regulate tumour transformation may provide new ground for clinical intervention in terms of prevention, diagnosis and therapy.

Original languageEnglish
Pages (from-to)805-815
Number of pages11
JournalOncogene
Volume35
Issue number7
DOIs
Publication statusPublished - Feb 18 2016

Fingerprint

Neoplastic Stem Cells
Thyroid Neoplasms
Stem Cells
Thyroid Gland
Neoplasms
Health Services Needs and Demand
Carcinogenesis
Neoplasm Metastasis
Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Zane, M., Scavo, E., Catalano, V., Bonanno, M., Todaro, M., De Maria, R., & Stassi, G. (2016). Normal vs cancer thyroid stem cells: The road to transformation. Oncogene, 35(7), 805-815. https://doi.org/10.1038/onc.2015.138

Normal vs cancer thyroid stem cells : The road to transformation. / Zane, M.; Scavo, E.; Catalano, V.; Bonanno, M.; Todaro, M.; De Maria, R.; Stassi, G.

In: Oncogene, Vol. 35, No. 7, 18.02.2016, p. 805-815.

Research output: Contribution to journalArticle

Zane, M, Scavo, E, Catalano, V, Bonanno, M, Todaro, M, De Maria, R & Stassi, G 2016, 'Normal vs cancer thyroid stem cells: The road to transformation', Oncogene, vol. 35, no. 7, pp. 805-815. https://doi.org/10.1038/onc.2015.138
Zane M, Scavo E, Catalano V, Bonanno M, Todaro M, De Maria R et al. Normal vs cancer thyroid stem cells: The road to transformation. Oncogene. 2016 Feb 18;35(7):805-815. https://doi.org/10.1038/onc.2015.138
Zane, M. ; Scavo, E. ; Catalano, V. ; Bonanno, M. ; Todaro, M. ; De Maria, R. ; Stassi, G. / Normal vs cancer thyroid stem cells : The road to transformation. In: Oncogene. 2016 ; Vol. 35, No. 7. pp. 805-815.
@article{6e0382b07cb844899f784cdd2cd412e5,
title = "Normal vs cancer thyroid stem cells: The road to transformation",
abstract = "Recent investigations in thyroid carcinogenesis have led to the isolation and characterisation of a subpopulation of stem-like cells, responsible for tumour initiation, progression and metastasis. Nevertheless, the cellular origin of thyroid cancer stem cells (SCs) remains unknown and it is still necessary to define the process and the target population that sustain malignant transformation of tissue-resident SCs or the reprogramming of a more differentiated cell. Here, we will critically discuss new insights into thyroid SCs as a potential source of cancer formation in light of the available information on the oncogenic role of genetic modifications that occur during thyroid cancer development. Understanding the fine mechanisms that regulate tumour transformation may provide new ground for clinical intervention in terms of prevention, diagnosis and therapy.",
author = "M. Zane and E. Scavo and V. Catalano and M. Bonanno and M. Todaro and {De Maria}, R. and G. Stassi",
year = "2016",
month = "2",
day = "18",
doi = "10.1038/onc.2015.138",
language = "English",
volume = "35",
pages = "805--815",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Normal vs cancer thyroid stem cells

T2 - The road to transformation

AU - Zane, M.

AU - Scavo, E.

AU - Catalano, V.

AU - Bonanno, M.

AU - Todaro, M.

AU - De Maria, R.

AU - Stassi, G.

PY - 2016/2/18

Y1 - 2016/2/18

N2 - Recent investigations in thyroid carcinogenesis have led to the isolation and characterisation of a subpopulation of stem-like cells, responsible for tumour initiation, progression and metastasis. Nevertheless, the cellular origin of thyroid cancer stem cells (SCs) remains unknown and it is still necessary to define the process and the target population that sustain malignant transformation of tissue-resident SCs or the reprogramming of a more differentiated cell. Here, we will critically discuss new insights into thyroid SCs as a potential source of cancer formation in light of the available information on the oncogenic role of genetic modifications that occur during thyroid cancer development. Understanding the fine mechanisms that regulate tumour transformation may provide new ground for clinical intervention in terms of prevention, diagnosis and therapy.

AB - Recent investigations in thyroid carcinogenesis have led to the isolation and characterisation of a subpopulation of stem-like cells, responsible for tumour initiation, progression and metastasis. Nevertheless, the cellular origin of thyroid cancer stem cells (SCs) remains unknown and it is still necessary to define the process and the target population that sustain malignant transformation of tissue-resident SCs or the reprogramming of a more differentiated cell. Here, we will critically discuss new insights into thyroid SCs as a potential source of cancer formation in light of the available information on the oncogenic role of genetic modifications that occur during thyroid cancer development. Understanding the fine mechanisms that regulate tumour transformation may provide new ground for clinical intervention in terms of prevention, diagnosis and therapy.

UR - http://www.scopus.com/inward/record.url?scp=84958636857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958636857&partnerID=8YFLogxK

U2 - 10.1038/onc.2015.138

DO - 10.1038/onc.2015.138

M3 - Article

C2 - 25961919

AN - SCOPUS:84958636857

VL - 35

SP - 805

EP - 815

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 7

ER -